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The history, orlgm, pathology, diagnosis, treatment and
prognosis of chordoma involving the axial skeleton are
reviewed, and the clinical histories of 3 cases of chordoma
are given, noting some remarkable features, along with
one case misdiagnosed as chordoma on the radiological
appearance of the sacrum and treated as such, which
later proved to be a case of multiple myelomatosis.
S. Afr. Med. J., 48, 383 (1974).
Chordoma is a relatively slow-growing invasive neoplasm
which relentlessly destroys and replaces the bone in which
it develops, manifesting little disposition to distant spread,
but occasionally pursuing a more progressive course pro-
ducing widespread metastases. It arises from embryonic
remnants of the notochord, which undergo neoplastic
proliferation and develop most commonly in the axial
skeleton at the base of the skull (in the dorsum sellae or
clivus), or in the sacrococcygeal region; infrequently in
the vertebrae; and rarely extranotochordally.
Therapy by means of surgery and radiotherapy remains
disappointing. Theoretically, complete surgical extirpation
should be curative but is seldom possible, while chordoma
is said to be radioresistant. One is therefore confronted
with a choice between two unsatisfactory alternatives.
However, there is sufficient evidence that radiotherapy can
cause growth restraint and tumour shrinkage, and autho-
rities are agreed that if complete extirpation is impossible,
the surgeon should remove as much of the tumour as is
possible, at repeated attempts if necessary, and certainly
followed by radiotherapy, because such combined therapy
is bound to result in relief of pain and may even prolong
life expectancy. However, the neoplasm is so seldom en-
countered that the experience of a single observer is likely
to be limited to a few cases.
We have observed significant palliation following com-
bined surgery and radiotherapy for chordoma, although
eventually the patients succumb to the disease. Willis'
states that in 1857 several examples of small gelatinous
masses projecting into the cranial cavity from the clivus
were described by Luschka,' Hasse; Zenker: and Virchow.'
Virchow regarded these as cartilaginous and because of
the vacuolated character of their cells, named them ecchon-
drosis physaliphora. In 1858 Milller6 recorded a careful
study of the notochord in the developing skull, and express-
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5
ed th .. e VIeW that the so-called ecchondroses were really
denved fr~m notochordal remnants. Fischer and Steiner'
were the fIfSt to call a tumour situated at the base of the
s~u~l a malignant chordoma, and Linck' recorded a
SImIlar tumour projecting into the pharynx. Chordomas in
the sacrococcygeal region were first recorded by Feldmann'
and Mazzia." Soon, however, a number of chordomas
were recorded in the literature, and it became evident
that sacral chordomas were commoner than cranial chor-
domas. Chordomas of the vertebral column were then
recognised by Chapell" and Giithert,12 but these are
extremely rare.
EMBRYOLOGY
~e ~e~ to the understanding of the nature of chordomas
lies In mformation related to the development of noto-
chordal tissue in the embryo. In Beesley and Johnston's
Manual of Surgical Anatomy,U it is stated that during
the second week of intra-uterine life, a longitudinal furrow,
termed the neural groove, appears on the dorsal aspect
of the embryo. The walls and floor of this groove are
f~rmed by a thickening of the surface ectoderm. At a
~lightly later stage the margins of the groove unite and
It becomes converted into the neural tube which subse-
quen~ly gives origin to the whole of the n'ervous system.
At fIrst the dorsal part of the neural tube is continuous
with the surface ectoderm, but the two soon become
separated by mesoderm which grows in from each side.
On the ventral aspect of the neural tube lies the notochord
or primitive skeletal axis, which is derived from the
anterior end of the primitive streak. The mesoderm on
each side of the notochord and the neural tube become
divided into a series of segments or somites which are
sepa~ated from one another by intersegmental septa.
PortIOns of the somites grow medially and surround the
notochord and the neural tube to form the membranous
vertebral column. The membranous column is gradually
replaced by cartilage and the notochord now passes along
the whole length of tlIe column within the cartilaginoU5
vertebrae and the intervertebral tissue.
At the ~ranial end of. the column, it traverses the body
of the aXIS and passes In the suspensory ligament of the
dens to the part of the cartilaginous base of the skull
which becomes the basi-occiput and the basisphenoid.
From. the second n:onth onwards the notochord begin5
to shrmk. The portIOns of the notochord which become
enclosed in the bone finally disappear with the onset of
ossi~ication. Between adjacent vertebral bodies, a part
perSIsts as the nucleus pulposis of the intervertebral discs.
Remnants of notochordal tissue that should have disap-
peared may persist in certain situations, giving rise to
the tumour known as a chordoma. Lichtensteinl< points
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out that the development of the notochord is intimately
associated with the development of both ectodermal and
mesodermal tissues, which is significantly reflected in the
cytology of chordomas. Thus, in any given instance, the
tumour may be composed of epithelial-like structures, or,
on the other hand, may closely resemble spindle-cell
sarcoma, and both types of cell growth may be observed
frequently in the same neoplasm. To be sure, the degree
of differentiation, the rapidity of growth, and the extent
of the neoplasia, are all factors influencing the cytology of
any particular chordoma. Thus, at one extreme, one may
observe well-differentiated chordomas containing regular
cavities lined by cuboidal epithelium, closely resembling
the primitive notochordal tube, and at the other, distinctly
anaplastic chordomas whose recognition as such may
occasion considerable difficulty.
INCIDENCE, SITE, AGE, SEX, AND
DURATION
Chordomas are recorded as rare neoplasms. Stewart and
Morin15 found 4 in 350, and Willis' 5 in over a 1 000
necropsies in which they were especially looked for.
Harvey and Dawson'· reviewed 240 cases and found a
site distribution as follows: cranial 37%, vertebral 12%.
and sacrococcygeal 51 %. Lichtenstein" noted that the
sacrococcygeal and basicranial sites account for fully 90%
of all reported instances of chordoma. No age is exempt,
with the average age differing according to the site of
origin; for basicranial tumours it is 35 years, while for
sacrococcygeal tumours it is 51 years. Higinbotham et a/."
reviewed -46 cases of chordoma treated at the Memorial
Hospital, New York, from 1930 to 1965, which included
30 cases of sacral origin, 10 of vertebral origin, 5 of
basisphenoidal and 1 of extranotochordal origin, and
found that the ages varied from 2t to 71 years, with a
ratio of males to females of 2 to 1. Mabrey," analysing
150 recorded cases, found delays of 3 years and more
from the onset of symptoms to the first treatment. The
average duration of life, according to Littman," from
first manifestation to final demise, is 4 years. Pearlman
and Friedman'· found that 50% of their series of 15
patients survived longer than 5 years, with no evidence of
regrowth of the tumour, and with the patients all asympto-
matic.
PATHOLOGY
Willis' states that the typical chordoma is a slow-growing,
well-defined, lobulated tumour, consisting of a soft gela-
tinous tissue, often within areas of haemorrhage, cystic
degeneration or calcification, and sometimes within areas
of more solid white tissue. It invades, distends and destroys
the neighbouring bones, and extends into adjacent regions;
the nasopharynx or orbits, or into the retroperitoneal
tissues, or into the thighs and buttocks. Sacrococcygeal
tumours may attain a very large size weighing up to 10
kg or more. The spheno-occipital growths do not attain
such a large size; they project either into the pharynx or
into the cranial cavity. Microscopically, representative
sections of tissue are easy to recognise'- The cells are
usually aggregated in regular groups, separated by stromal
connective tissues or by the mucoid matrix of the tumour
itself. The characteristic cytoplasmic and intercellular
vacuolation is prominent and vacuolated cells may assume
signet-ring forms. In areas of greatest mucus formation,
only scattered islets of cells may remain in a sea of
mucinous matrix. Multinucleated cells are not uncommon.
Mitotic figures are rare. uclear vacuolation has been
described but is unusual.
METASTASES
Chordomas are said seldom to metastasise, yet metastases
have been reported in the regional lymph nodes;"'" in
the soft tissues of the scapula and buttock;' in the liver,
lungs and skin;'" and in many organs.' Higinbotham
et al." state that local recurrences and distal metastases
are more common than is generally appreciated. In their
series of 46 cases they found distant metastases present
in 43%.
SYMPTOMS AND SIGNS
Involvement of the Clivus
The symptoms are variable and one or more of the
following may be present: headache, diplopia, paresis of
facial and tongue muscles on one side, defects of speech
and difficulty in swallowing, a troublesome stiff neck and
some loss of balance. The signs are usually the presence
of a central pharyngeal mass projecting into the vault of
the nasopharynx where it grows to produce nasal obs-
truction and deafness, paresis of the various muscles of
the eyeball, face and tongue, impairment of speech and
dysphagia. X-ray films may reveal a lobulated soft tissue
mass projecting into the vault of the nasopharynx. There
may be erosion of the body of the sphenoid, that is, de-
struction of the clivus. Inside the skull, there may be in-
volvement of the clinoid processes with enlargement of the
dorsum sellae. Tomograms may be necessary to demon-
strate such changes. A myelogram may reveal lifting of the
dura from the level of the dens to just behind the posterior
clinoid processes, demonstrating intracranial and subdural
extension of the chordoma.
Involvement of the Sacrococcygeal Region
The symptoms are invariably pain due to pressure from
the pelvic mass, with a tendency for the pain to shoot
down both legs. The pain may be excruciating at times.
As the mass increases in size it may cause dysfunction of
the rectum and the bladder with progressive constipation
and frequency, sciatica, saddle anaesthesia and sphincter
The signs may be a bulging mass projecting inwards and
tending to fill the pelvis, or extending outwards to pro-
duce an external mass over the sacrum or in one or other
buttock. X-ray films may, in the early stage of the disease,
merely reveal a suspicious area of ground-glass appearance,
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where the trabeculae of the sacrum look as if they have
been rubbed out. Later there may be frank destruction of.
the trabeculae of the sacrum and coccyx, and this may
be so extensive that it looks as if the sacrum and coccyx
have been surgically removed. A soft tissue mass is
"en~rally discernible but there is no periosteal reaction
~resent. Tomograms are of value to define the limits of
the lesion.
TREATMENT
The treatment of choice for chordoma is complete surgical
extirpation, but since this is seldom feasible, it is impor-
tant that the surgeon remove as much of the tumour as
is possible, followed by postoperative radical radiotherapy
by means of supervoltage (1 - 10 MeV, i.e. million·electron-
volts) teleroentgen or telecobalt therapy. Although chor-
doma is reported to be a radioresistant tumour, pre-opera-
tive or postoperative radiotherapy, or radiotherapy for
the advanced inoperable or recurrent chordoma, should
not be withheld on this account, because chordomas are
also known to vary in radioresponsiveness, and there is no
doubt that in most cases radiotherapy produces not only
growth restraint and tumour shrinkage, with resultant
relief of pain and discomfort from pre~sure due to the
tumour mass, but also increases life expectancy. No
worth\Y.hi1e cancer chemotherapeutic agent is at present
available. MacCarthy et al." reported their experience in
treating sacrococcygeal chordomas by radical surgery
only, and in a preliminary report of their results, they
claim encouragement because 7 out of 18 patients are
without recurrence 1 -12 years after treatment.
Higinbotham et al." state that the radiotherapist should
not be discouraged easily in treating chordoma because
the response of the tumour to radiotherapy is often very
slow. Time and again there is but minor relief of pain
towards the end of treatment and little or no change in
tumour dimensions, but in the following month or two
the pain disappears completely as tumour regression be-
comes evident. They found that a tumour dose of 4 000
rads in 20 exposures over 4 weeks with pendulum super-
voltage teleroentgen therapy, was generally tolerated very
well, while 7 000 rads in 25 exposures over 5 weeks pro-
duced acute radiation reactions resulting in troublesome
cystitis and proctitis. In an analysis of their 46 patients
there were 30 of sacrococcygeal origin of which radio-
therapy only was given to 9, surgery only to 8 and
combined surgery and radiotherapy to 13. The specific
therapy schedules for the remaining 16 patients are not
clearly recorded. Their results are summarised in Table I.
Pearlman and Friedman'· report that the clinical course
of their 15 cases of chordoma who underwent radical
radiotherapy following biopsy, or incomplete surgical re-
moval, or complete surgical extirpation, was as follows:
7 survived longer than 5 years; 7, including 2 with basi-
sphenoid tumours, did not benefit significantly, the longest
survival being 3,5 years. One patient alive with disease
is at risk for only 1,5 years.
In an analysis of 113 cases cited in the literature
to determine optimum dosage for irradiation of chordoma,
Pearlman and Friedman" found that tumour doses of
less than 4000 rads in 5 weeks offer little likelihoQd of
tumour restraint, while tumour doses of 8 000 rads in 7
weeks are more likely to be successful. Field sizes are not
mentioned. They point out, however, that there are failures
in every dose range, and that the risk of radiation injury is
very real in the higher dose ranges mentioned. Repeated
courses of irradiation increase the risk. When the first
adequate course of irradiation fails, it is unlikely that
repeated courses will succeed. Table II summarises their
results.
TABLE 11. ANALYSIS OF THE RESULTS OF 113 CASES




(rads) No. % No. % No. %
Up to 4000 47 85 5 9 3 6
4001 - 6 000 18 60 6 20 6 20
6001 -8000 8 43 5 31 4 26
Over 8000 2 1 8 80
Total 75 66 17 15 21 18
A number of authors recommend hemicorporectomy
for the appropriate case, that is, where patient and family
and medical staff are fully cognizant of all it entails, not
only with regard to the magnitude of the procedure itself.
but also to the vigorous commitment of all to total phy-
sical, mental and economic rehabilitation.""'"
7
TABLE I. CHORDOMA SURVIVAL RATES FOLLOWING TREATMENT AT MEMORIAL HOSPITAL, NEW YORK,
1930 - 1965"
Location
of No. living with disease up to death liVing free
chordoma or last follow-up of disease Total
Duration (years) 2,5 5,0 7,5 10 12,5 15 5,0 10 15
Sacrococcy 5 9 4 5 2 2 1 2 30
Sphenoidal 2 2 5
Vertebral 5 2 2 10
Scapula 1 1
Total 13 13 6 5 2 3 2 46
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PROGNOSIS
Willis' observes that the ultimate outlook for cases of
chordoma is uniformly poor, but many tumours are of
slow growth and some patients survive for many years.
Stewart and Morin15 found that the average duration of
cranial cases from onset of symptoms was 2,8 years, and
of sacral cases 6,4 years. Even when complete removal of
the growth appears to have been achieved, the prognosis
must be guarded. In Stewart's case recurrence ensued
after 5 years of apparent freedom from disease following
excision. The total duration of this case from first appea-
rance of the tumour to death was 19 years. Higinbotham
et al." point out that in these chronic types of cancer,
where 5-year survivals are common, even without treat-
ment, it is difficult to express the benefits of treatment
in quantitative terms. Little data of the results of rad;o-
therapy have be::n found in the literature. In a prolonged
follow-up of these patients the better quality of survival
in treated patients is quite striking when compared to the
pain, depression, inability to work, and visceral dysfunction
with secondary infection, which are the lot of those
untreated or not responding to treatment.
CASE REPORTS
It is impossible to give full descriptions of the case
histories of our 4 patients as they are rather extensive;
suffice it to state only the cardinal points.
Case 1
A White male journalist, 36 years of age, was referred on
16 August 1963 for radiotherapy, with the diagnosis of
a recurrent chordoma of the clivus, and w:th the following
case history.
In August 1958 he developed a 'blocked' no~e, nasal
discharge and deafness. Examination revealed a posterior
nasopharyngeal tumour 3,0 cm in diameter and 2.0 cm
in depth, clearly visible on raising the uvula. It was c'entral
in position and smooth in outline. There were no palpable
glands present in the neck. X-ray films showed no bone
erosion at the base of the skull, pituitary fossa or occipital
region. A biopsy and histological investigation confir-med
the clinical diagnosis of chordoma of the clivus.
On 23 October 1958 the patient was referred for tele-
cobalt therapy at the Meyerstein Institute of Radiotherapy,
~iddlesex_Hosp!tal. He was treated through 2 opposing
fIelds of )0 cm- placed on each side of the neck, to a
tumour dose of 7 200 rads in 40 exposures over 54 days,
from 27 October to 19 December 1958 (excluding Satur-
days and Sundays). Towards the end of treatment the
patient developed a sore throat, and over Christmas he
could only swallow jellies. He was in the habit of examinino
. b
hIS own throat regularly, and although his throat remained
sore for some time, looking red with streaks of yellow.
the tumour disappeared completely. He returned to South
Africa in January 1959.
In January 1962, after a 3-year period of good health
after the telecobalt therapy, he was shocked to notice a
recurrence of the tumour in his throat. There had been
no after-effects of the telecobaIr therapy, except that the
beard on his cheeks at the angles of the jaw did not grow
again. He was once again referred to London.
In April 1962 the tumour was operated on and removed
from the posterior nasopharynx, from where it had
extended into the basi-occiput. The surgeon felt that he
had removed the whole tumour, and in view of the
previous radical telecobalt therapy, did not refer the
patient for a further course. The patient returned to South
Africa and remained well for almost a year when in March
1963 the tumour recurred in the nasopharynx. The X-ray
films revealed involvement of the whole of the basi-occiput,
with penetration through to the brain side of the bone.
At this stage we were consulted about telecobalt therapy.
In view of the previous telecobalt therapy, we suggested
surgical removal of as much of the nasopharyngeal
tumour as possible, followed by telecobaIt therapy if
complete removal was found to be impossible. A large
swelling was present below the soft palate extending
upwards on the posterior wall of the nasopharynx out
of view. There was fasciculation and wasting of the right
side of the tongue with deilection to the right on pro-
trusion due to XIIth nerve involvement. A myelogram
revealed a lifting of the dura posteriorIy from the level
of the the dens to just behind the poster:or clinoid.
The displacement was considerable.
On 20 March 1963 the surgeon operated and approached
the tumour through the posterior fossa transdurally on
either side. A thorough removal of the tumour was
obtained. Sections of the tumour tissue removed showed
histologically the presence of chordoma. The patient made
an uneventful recovery and was discharged on 1 April
Fig. 1. Chordoma before treatment with telecobalt therapy.
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Fig. 2. Chordoma after treatment with telecobalt therapy.
1963. But on 19 April 1963, he was readmitted with
headache, nausea and vomiting and a diagnosis of
meningItis was made. Cerebrospinal fluid was normal,
however, and no bacterial growth could be cultivated.
A low-grade staphylococcal infection was assumed and
the patient put on Erythrocin every 6 hours. By 4
May 1963 the episode had cleared completely and the
patient was discharged. On 17 June 1963 the patient
had a similar bout which cleared on antibiotic therapy.
On 26 August 1963 the patient was referred to us with
slurred speech, slight deafness and a recurrent soft tissue
tumour of rubbery consistency but smooth in outline,
about 3,0 cm in diameter, situated centrally in the posterior
nasopharynx and bulging forwards onto the soft palate.
There were no palpable cervical lymph nodes present.
X-tay films revealed a bulging soft tissue mass with
erosion of the basi-occiput. There were no lung metastases
(Fig. 1). Pendulum telecobalt therapy was planned to
pass through an angle of 60° on both sides of the neck.
The treatment was administered, through windows of
6 x 6 cm' cut on either side of a plaster cast, to a
tumour dose of 6000 ra,ds in 20 exposures over 26 days,
at a source-tumour-distance of 60 cm.
The actual telecobalt therapy was administered as plan-
ned from 26 August to 19 September 1963 (excluding
Saturdays and Sundays), when he developed the maximum
clinical reaction that the normal tissues of the thro"at
will tolerate, namely a confluent membranous reaction,
and treatment had to be stopped when he had received
a tumour dose of 4683 rads delivered in 16 exposures
over 21 days. Ten days later the tumour was much
smaller, his speech less slurred and deafness less pro-
nounced. The telecobalt reaction had cleared, and it was
7
decided to give a further tumour dose of 1 100 rads in
4 days to bring the tumour dose up to 5 783 rads. The
patient tolerated the further treatment very well (Fig. 2).
The patient was followed up at regular intervals and
on 4 February 1964 the nasopharyngeal mass was barely
visible, his speech had improved, and he was back to doing
a full day's work. But he was beginning to have trouble
with double vision. Each eye on its own had excellent
vision, but co-ordination was faulty. We did not see him
again, but heard that he had had a rather checkered health
career, although he carried on with his work almost up to
the time when he died of his chordoma in January 1968,
almost 10 years after the diagnosis was made. Combined
surgery and telecobalt therapy kept the disease under
control for many years.
Case 2
A 65-year-old married woman was referred to us for
postoperative radiotherapy on 10 December 1970, with
the diagnosis of a chordoma of the sacrum with the
following history.
On 26 July 1966 an orthopaedic surgeon operated on
her for the removal of a chordoma of the sacrum. The
diagnosis was histologically verified. During the operation
she suffered cardiac arrest, which necessitated an imme-
diate thoracotomy and cardiac massage. The patient re-
covered most satisfactorily, but owing to the cardiac
arrest, removal of the chordoma was incomplete. A cause
for concern was that she developed a supraventricular
tachycardia and was rather hypotensive. The possibility
of a coronary thrombosis or pericardial tamponade was
entertained. The electrocardiogram taken was not diag-
nostic of coronary thrombosis and clinically there were
no signs of pericardial tamponade.
Up to November 1967, when there was a recurrence
of pain and discomfort in the sacral region, the patient
was very well. The clinical history from November on-
wards is very sketchy, all that could be elicited from the
patient was that she was operated upon on 2 occasions,
in November 1967 and again in January 1968, and re-
ceived radiotherapy on 4 occasions, in January 1968
(15 exposures); December 1968 (10 exposures); January
1969 (5 exposures); and in August 1969 (5 exposures).
On 10 December 1970, the patient developed pain in
the left buttock and experienced difficulty with defaeca-
tion. On 13 January 1971 examination revealed several
soft tender tumours of large size in the left gluteus maxi-
mus muscle, which were raising the skin. Rectal exami-
nation showed a lobulated tumour, bulging into the
pelvis from the left side, fixed to the pelvic wall and
almost completely closing off the rectum. X-ray films of
the pelvis revealed the absence of the sacrum, but the
presence of a soft tissue mass on the left side, pressing
on the rectum, which is revealed as a thin streak of air
to the pubic bone. The full bladder is pushed slightly to
the right side. The distal part of rectum and anus are
air-filled behind the symphysis pubis. X-ray films of the
chest indicated the presence of a large round opacity about
6,0 cm in diameter, at the base of the left lung, resting
on the paralysed left leaf of the diaphragm. The opacity
had apparently been present and remained static since
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the cardiac arrest and was regarded as an encysted and
inspissated effusion (Figs 3, 4 and 5).
In view of the favourable appearance of the skin, a
radical course of telecobalt therapy on the Theratron 60
unit was planned through two opposing fields 22 X 22
cm', one anterior and one posterior directed over the
left buttock, and a tumour dose of 2000 rads in 15
Fig. 3. Nodular masses present above and to the left of
the left buttock.
Fig. 4. Pelvis with sacmm and coccyx surgicaDy extirpated,
and soft tissue mass in pelvis. At the beginning of radio-
therapy, 13 January 1971.
Fig. 5. X-ray film of the chest reveals the large encysted
and inspissated mass in the left lung field resting on the
raised left leaf of the diaphragm. Metastases are now clearly
visible in the right lung field, 4 May 1971.
exposures over 21 days at a depth of 11,5 cm was admini-
stered from 13 January to 2 February 1971. Towards
the end of treatment there was some shrinkage of the
tumour masses with some relief of pain. Two months
after the patient was seen, although there was considerable
improvement, she still did not feel quite comfortable,
and while the defaecation was better, she still had the
sensation of fullness in the pelvis. The tumour masses
once again enlarged, causing considerable discomfort and
pain. X-ray films of the chest revealed the presence of
numerous small circular metastases clearly visible in the
right lung field. A second course of telecobalt therapy
was administered to the pelvis-l 000. rads in 5 exposures
through a single posterior field 17 x 17 cm'. This afforded
some relief and the same treatment was repeated once
more.
The patient went to Germany and we did not see her
again but heard that she had died on 21 December 1972,
after a long period of indifferent health. The course of
this patient's chordoma extended over a period of 6,5
years.
Case 3
A Provincial inspector aged 41 years was referred
for postoperative radiotherapy for a sacral chordoma
(histologically verified but incompletely removed surgi-
cally on 13 October 1964).
On 4 November 1964 the patient complained of pain
in his 'tail bone'. On examination no obvious lump could
be felt externally or per rectum. X-ray films revealed the
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right half of the sacrum removed surgically (Fig. 6).
T~lecobalt therapy on the Gammatron unit was planned
Fig. 6. X-ray film of pehis showing the right half of the
sacrum removed by surgery.
through 3 fields 11 x 9 cm'; one posterior and two
anterior, directed at the sacrum, to give a tumour dose
of 5400 rads at a depth of 12 cm with a focal-tumour-
distance of 65 cm in 20 exposures over 46 days. There
was an interval of 2 weeks due to gastro-enteritis and
severe diarrhoea aggravated by the radiotherapy. He
developed a left-sided exophthalmos with dilated pupil.
and anaesthesia of the skin of the forehead on that side,
due to a metastasis at the base of the skull in the region
of the pituitary gland.
The pain and discomfort in the sacral region cleared up
almost completely but the patient was suffering from
severe headaches and his general condition had deterio-
rated rapidly. We decided to irradiate the brain. A course
of telecobalt therapy on the Gammatron unit was planned
through 2 opposing lateral fields 7 x 5 cm' directed at
the pituitary fossa, to give a tumour dose of 5 800 rads
in 20 exposures over 26 days. After the first exposure of
165 rads tumour dose the patient became very ill and he
died on the 24 December 1964. From the date of diagnosis
to death was 2-} months.
At necropsy the brain showed no obvious abnormality,
bu t in the sella turcica there was infiltration of the left
half of the pituitary gland by a metastatic chordoma.
The right adrenal was replaced by a metastatic chordoma
and weighed 150 g. In the left adrenal there was a
metastastic lesion in the medulla, although peripheral
cortical tissue was still present. The reticulo-endothelial
system showed no obvious abnormality. Obvious tumour
tissue was present in the sacrum and a sinus extended
from this tumour to the retrovesical pouch. Histological
examination of this tumour showed the features of chor-
doma with large vacuolated mucin-secreting cells.
The case is remarkable for the rapid course of the
disease, and the metastases to the pituitary gland and
both suprarenal glands from a sacral chordoma.
Case 4
A White diamond-drill operator, 41 years of age, was
referred for radiotherapy with a diagnosis of chordoma
of the sacrum, and with the following case history.
In December 1969 the patient was manipulated for
chronic low backache with considerable relief of pain.
In April 1970 he slipped while lifting a stretcher, injured
his back, and suffered severe pain which gradually sub-
sided on rest. In May J970 his back became so painful
that he had to seek medical advice, and an X-ray film
of the back showed displaced discs between L5-S1 and
L4-L5.
On 20 June 1970 a surgeon performed a laminectomy
and removed a large protruding disc between L4-L5 and
a smaller one between L5-S 1, with considerable relief of
pain. About 3 months later, after a haemorrhoidectomy,
the patient suffered from episodes of low backache and
an X-ray film showed a large erosion of the sacrum, and a
possible smaller one at the junction of the inferior ramus
of the os pubis on the right side and the ischium, suggestive
of a chordoma of the sacrum, but myelomatosis and
osteolytic metastases were considered.
Fig. 7. Chordoma of the sacmm, before treatment, 30
September 1970. Note the extensive erosion of the sacmm
including the sacro-iIiac joints on either side, which is
rather typical of a chordoma of the sacrum. But there is
also a smaller erosion of the superior ramus of the os
pubis at the junction with the inferior ramus on the
right side, which raised the possibility of an X-ray diag-
nosis of mye:omatosis. .
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On 30 September 1970 the patient complained of
severe low backache, and great difficulty in sitting for
any length of time. The X-ray film confirmed the diagnosis
of chordoma of the sacrum (Fig. 7). We considered
having a biopsy of the sacrum done, but decided against
it. We proceeded to plan a course of telecobalt therapy
on the Theratron 60 unit. A 3-field cross-fire technique
was employed, with 1 posterior and 2 anterior fields,
each 15,5 x 15,5 cm', directed at the sacrum at a
source-tumour-distance of 60 cm to deliver a tumour dose,
at a depth of 8,0 cm, of 3000 rads in 15 exposures
over 19 days. The patient was placed on his stomach,
with the posterior field falling perpendicular onto the
sacrurn from above, and the 2 anterior fields angled at
130° on either side from below. The treatment was
administered through all 3 fields every day for 5 days
a week.
On 18 January 1971 it was noted that the backache had
.mproved and that he was now able to sit with comfort.
However, he now complained of pain in the ribs on
both sides at about the level of the 6th rib. X-ray films
revealed no obvious pathological changes in the ribs.
Since the chordoma of the sacrum was showing evidence
of healing, the appearance still suggested activity and
a further course of telecobalt therapy was decided upon.
On this occasion a tumour dose of 2000 rads, through 1
anterior field 13 x 13 cm' not previously irradiated, was
planned and administered in 10 exposures over 12 days.
On 22 March 1971 the patient reported severe pains
in the ribs on both sides of the chest. An X-ray film of the
chest revealed pathological fractures of the 2nd and 6th
ribs on the right side, and the 8th rib on the left side.
In view of these findings the diagnosis of multiple myelo-
matosis became a serious possibility, but all the blood
and urine tests were negative. Another course of telecobalt
therapy was planned to relieve the pain in the ribs, and,
since the sacral lesion was incompletely healed, a third
course of telecobalt therapy was given to the sacrum.
One posterior field 14 x 8 cm' at the level of T5 and a
posterior field 14 x 10 cm' over the sacrum toa dose
of 2 000 rads in 10 exposures over 12 days, were delivered.
On 1 April 1971 a bone marrow biopsy was performed.
Microscopical examination of a section from the 6th rib
showed the presence of tumour tissue, the histological
appearances of which were consistent with those of
multiple myelomatosis.
Oil 5 April 1971, the patient was referred for cytostatic
therapy which included high daily oral doses of L-phenyl-
alanine mustard (L-PAM) and 6-methylprednisoline. The
patient showed a good response to treatment and the
L-PAM was reduced to low oral maintenance doses with
intermittent 6-methylprednisoline booster courses. In Sep-
tember 1972 X-rays showed progression of his lesions
and he was then put on cyclophosphamide (Endoxan).
intravenously. He did not show any improvement on this
regimen, and developed a patholog:cal fracture of the
femur. The fracture was stabilised by means of a Kun-
schner pin, and he then received a course;. of intravenous
vincristine and bleomycin and high doses of prednisone.
His response to this form of treatment was most
encouraging, and when I~st seen on 12 December 1972
he was remarkably fit.
This case is remarkable br the misleading, rather
typical' X-ray film appearance of a chordoma of the
sacrum.
Fig. 8. Chordoma of the sacmm, after treatment, 14 Sep-
tember 1971. Note the erosion of the sacrum has almost
completely been replaced by new bone formation and
1rabeculation.
CONCLUSION
Although chordoma is seldom cured, it is usually slow-
growing, enabling the patient to survive for many years
with the disease, but generaI.y, in the absence of adequate
surgery and/or radical radiotherapy, suffering great dis-
comfort and agonising pain, which at times may be
excruciating. The treatment of choice is, therefore, com-
plete surgical extirpation, or failing this, removal of as
much of the tumour as possibl~, followed by postoperative
radical radiotherapy, with supervoltage units in both
cases, and in all inoperable and recurrent cases, with a
repeat course if necessary, especially where there has
been a response in the. past, in an all-out effort to relieve
the patient of any d:scomfort and pain and to prolong a
life worth living.
Professor Fichardt was in receipt of a grant from the
National Cancer Association of South Africa.
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